ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1059

Assessing the Relationship Between Multidimensional Area Level Indicators and Lupus Disease Activity in Children

Chelsea Reynolds1, Natasha Ruth2, Paul Nietert1, Mileka Gilbert1, Emily Vara1 and Joyce Chang3, 1Medical University of South Carolina, Charleston, SC, 2Medical University South Carolina, Charleston, SC, 3Boston Children's Hospital, Boston, MA

Meeting: ACR Convergence 2025

Keywords: Environmental factors, Pediatric rheumatology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1055–1087) Healthcare Disparities in Rheumatology Posters

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Recent research suggests that multidimensional area-level indicators, including the Social Vulnerability Index (SVI), Area Deprivation Index (ADI) and Childhood Opportunity Index (COI), associate with childhood-onset systemic lupus erythematosus (cSLE) outcomes in primarily urban populations. However, to date, there are no studies that have assessed the utility of multidimensional area level indicators in children with cSLE living in rural areas. The goal of this study is to estimate relationships between neighborhood conditions and disease activity in children with cSLE who live in a mixed rural and urban setting. We hypothesized that patients with cSLE living in areas with higher social vulnerability and area-level deprivation have increased lupus activity.

Methods: We retrospectively evaluated electronic health record data for pediatric patients with cSLE across three pediatric rheumatology clinics at a single center between January 1, 2020 and December 31, 2024. We included patients with a diagnosis of cSLE before 18 years of age, a residential address within South Carolina, and excluded PO box addresses. Chart reviews were conducted to collect demographic data and addresses were linked to census tract-level indicators, including ADI, SVI and COI, ranked at state and national levels. We assessed each patient’s SLEDAI-2K score at their first clinic or hospital encounter associated with a SLE diagnosis.

Results: Baseline characteristics have been established for a cohort of 85 children with cSLE. The majority of patients identified as Black 65 (79%), followed by White 11 (13%), Latino/a 6 (6%), Asian 1 (1%), and Other 1 (1%). The cohort was predominantly female (87.1%), with a mean age at diagnosis of 13.0 years (range: 6–17). The mean SLEDAI-2K at the initial encounter was 14.4 (range: 0-38). Most participants (40%) lived in areas with low state-ranked SVI scores (mean 0.42), with no significant correlation with initial SLEDAI-2K (R= 0.014). National SVI levels were higher, with most patients classified in medium-to-high (51.2%) SVI category (mean 0.69), with no significant correlation with initial disease activity (R = 0.0223). Similarly, neither state nor national ADI rank correlated with initial SLEDAI-2K (R = 0.106 and 0.0905, respectively). Most patients lived in areas with very low (35.3%) state-ranked child opportunity and very low (38.8%) nationally ranked opportunity. Again, no significant correlation was found between COI and initial disease activity (R = 0.067 and 0.050, respectively).

Conclusion: In a mixed rural and urban population, we did not observe significant associations between area-level measures of social vulnerability, area deprivation or childhood opportunity (COI) and lupus disease activity, as measured by SLEDAI-2K score at initial presentation to rheumatology care. Despite the cohort’s residence in predominantly deprived and low-opportunity areas, these indicators did not appear to predict lupus severity at first presentation to care. These findings highlight limitations in the use of available area-level indicators to explain pediatric lupus outcomes in mixed rural and urban areas.


Disclosures: C. Reynolds: None; N. Ruth: None; P. Nietert: None; M. Gilbert: None; E. Vara: None; J. Chang: Century Therapeutics, 2.

To cite this abstract in AMA style:

Reynolds C, Ruth N, Nietert P, Gilbert M, Vara E, Chang J. Assessing the Relationship Between Multidimensional Area Level Indicators and Lupus Disease Activity in Children [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/assessing-the-relationship-between-multidimensional-area-level-indicators-and-lupus-disease-activity-in-children/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-the-relationship-between-multidimensional-area-level-indicators-and-lupus-disease-activity-in-children/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology